Table 1 Correlation factors between tumor volumes and average ratios of lymphocytes expressing CD107a, granzyme B or perforin in tumors from LLC1 or MC-38 tumor-bearing mice intraperitoneally dosed with anti-PD-1 antibody.

From: Comprehensive immunophenotyping reveals distinct tumor microenvironment alterations in anti-PD-1 sensitive and resistant syngeneic mouse model

  

LLC1/tumors

MC-38/tumors

CD107a+

Granzyme B+

Perforin+

CD107a+

Granzyme B+

Perforin+

CD4+T cells

Isotype control

0.555

− 0.216

− 0.760

0.822

0.436

0.350

Anti-PD-1 mAb

0.075

− 0.457

0.590

0.473

− 0.975**

− 0.995**

CD8+T cells

Isotype control

0.431

− 0.199

− 0.936*

0.966**

0.193

0.502

Anti-PD-1 mAb

0.287

0.818

0.367

− 0.484

0.419

− 0.497

Tregs

Isotype control

0.768

0.829

− 0.326

0.778

0.583

0.758

Anti-PD-1 mAb

− 0.554

− 0.798

0.788

0.887*

0.554

− 0.464

B cells

Isotype control

0.865

− 0.394

− 0.401

0.956*

− 0.104

− 0.202

Anti-PD-1 mAb

− 0.083

0.112

− 0.868

0.930*

0.315

− 0.405

NK cells

Isotype control

0.499

0.584

− 0.466

0.960**

0.954*

0.394

Anti-PD-1 mAb

0.499

− 0.135

− 0.409

0.703

− 0.486

− 0.003

NKT cells

Isotype control

0.552

− 0.016

− 0.451

0.962**

0.511

0.664

Anti-PD-1 mAb

− 0.500

− 0.462

0.254

0.770

− 0.224

− 0.934*

  1. Correlation factor: r, *P < 0.05, **P < 0.01.